M. Bernengo

发表

Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T‐cell lymphoma: a single center clinical experience with long‐term follow‐up data and a brief overview of the literature

Paola Savoia, Robert Knobler, Pietro Quaglino, 2013, International journal of dermatology.

European Organization of Research and Treatment of Cancer (EORTC) Lymphomas (ISCL) and the cutaneous lymphoma task force of the Sézary syndrome: a proposal of the International Society for Cutaneous Revisions to the staging and classification of mycosis fungoides and

R. Dummer, G. Burg, N. Pimpinelli, 2009 .

Reciprocal Modulation of Circulating CD4+CD25+bright T Cells Induced by Extracorporeal Photochemotherapy in Cutaneous T-Cell Lymphoma and Chronic GRAFT- Versus-Host-Disease Patients

P. Quaglino, P. Savoia, M. Fierro, 2009, International journal of immunopathology and pharmacology.

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Nicola Pimpinelli, Reinhard Dummer, Peter Heald, 2007, Blood.

Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.

P. Quaglino, M. Fierro, M. Bernengo, 2007, Haematologica.

Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy

P. Quaglino, P. Savoia, M. Bernengo, 2004, The British journal of dermatology.

Thymopentin in SÉzary Syndrome: Clinical and Immunological Effects

M. Bernengo, M. Novelli, A. Appino, 1994 .

microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C

Francesca Orso, Daniela Taverna, Michael B. Stadler, 2011, The EMBO journal.

Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome

T. Nardò, P. Quaglino, S. Ribero, 2015, International journal of dermatology.

Variable CD 7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma ( SeÂzary Syndrome )

M. Polansky, S. Lessin, E. Vonderheid, 2010 .

The Sézary syndrome: hematologic criteria.

E. Vonderheid, M. Bernengo, 2003, Hematology/oncology clinics of North America.

Zosteriform Cutaneous Metastases: A Literature Meta‐Analysis and a Clinical Report of Three Melanoma Cases

P. Quaglino, P. Savoia, T. Deboli, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp.

T. Nardò, P. Savoia, M. Bernengo, 2011, European journal of dermatology : EJD.

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

P. Ascierto, A. Testori, E. Simeone, 2014, Journal of Translational Medicine.

F9 gene

M. Bernengo, Dr. W. K. Tang, Dr. W. K. Tang, 2018 .

Cytotoxic/natural killer cell cutaneous lymphomas

H. Müller-Hermelink, C. Meijer, S. Chimenti, 2003, Cancer.

Prognostic differences across sexes in melanoma patients: what has changed from the past?

P. Quaglino, S. Ribero, S. Osella-Abate, 2014, Melanoma research.

Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study — the Italian multidisciplinary group on melanoma

V. de Giorgi, N. Pimpinelli, P. Quaglino, 2015, Melanoma research.

Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp.

P. Quaglino, M. Fierro, P. Fava, 2010, The American Journal of dermatopathology.

Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells

Federica Briatore, M. Eandi, E. Ugazio, 2004, Anti-cancer drugs.

TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.

P. Quaglino, M. Fierro, M. Bernengo, 2008, The Journal of investigative dermatology.

TCRc-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous

P. Quaglino, M. Fierro, M. Bernengo, 2008 .

Expression and role of integrin receptors in Sézary syndrome.

P. Marchisio, P. Savoia, O. Cremona, 1992, The Journal of investigative dermatology.

Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.

M. Weichenthal, J. Becker, R. Dummer, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients

P. Quaglino, P. Savoia, S. Osella-Abate, 2001, Journal of cutaneous pathology.

Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data

P. Quaglino, P. Savoia, S. Osella-Abate, 2004, Melanoma research.

Expression Pattern of Chemokine Receptors and Chemokine Release in Inflammatory Erythroderma and Sézary Syndrome

P. Quaglino, M. Fierro, M. Bernengo, 2006, Dermatology.

Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma

S. Pileri, M. Baccarani, L. Pagano, 2005, Cancer.

Gemcitabine as Frontline Treatment for Cutaneous

S. Pileri, M. Baccarani, L. Pagano, 2005 .

Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre

T. Nardò, P. Quaglino, P. Savoia, 2010, Melanoma research.

Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study.

R. Foà, M. Colombo, N. Cascinelli, 1994, Human gene therapy.

Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis

P. Savoia, M. Bernengo, M. Novelli, 1998, Journal of cutaneous pathology.

Serum Levels of the Th1 Promoter IL-12 and the Th2 Chemokine TARC Are Elevated in Erythema Multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Correlate with Soluble Fas Ligand Expression

C. De Simone, P. Quaglino, P. Savoia, 2007, Dermatology.

Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients.

P. Quaglino, V. Allizond, D. Scalas, 2011, European journal of dermatology : EJD.

Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood.

P. Quaglino, M. Fierro, M. Bernengo, 2009, The Journal of investigative dermatology.

Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects

M. Fierro, M. Bernengo, A. Comessatti, 2009, Archives of Dermatological Research.

Chemotherapy in cutaneous T-cell lymphoma

P. Zinzani, N. Pimpinelli, R. Alterini, 2009 .

Primary cutaneous B-cell lymphoma - Reply

S. Pileri, A. Pileri, S. Chimenti, 2006 .

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.

G. Burg, M. Pittelkow, R. Willemze, 2002, Journal of the American Academy of Dermatology.

Cutaneous Intravascular Lymphoma following Extravascular Lymphoma of the Lung

M. Bernengo, R. Ponti, M. Novelli, 2004, Dermatology.

Phase II Trial of Oral Panobinostat (LBH589) in Patients with Refractory Cutaneous T-Cell Lymphoma (CTCL).

J. Becker, R. Dummer, C. Lebbé, 2008 .

Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.

P. Quaglino, P. Savoia, M. Fierro, 1997, Dermatology.

Functional properties in Sézary cells with an unusual phenotype.

M. Bernengo, F. Lisa, M. Meregalli, 1985, Clinical immunology and immunopathology.

In Vitro and In Vivo Effect of Thymostimulin in Melanoma Patients

M. Bernengo, M. Bernengo, M. Novelli, 1984 .

Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype.

R. Foà, D. Catovsky, P. Lusso, 1982, Leukemia research.

Atopic dermatitis in a phenylketonuric untreated patient

M. Spada, M. Fierro, E. Marra, 2015, International journal of dermatology.

Serum interleukin‐13 levels are increased in patients with Stevens–Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme

C. De Simone, P. Quaglino, A. Parodi, 2007, The British journal of dermatology.

Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients.

P. Tosco, R. Fruttero, P. Campiglia, 2012, Nitric oxide : biology and chemistry.

Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.

P. Quaglino, P. Savoia, M. Bernengo, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Early recruitment in the human myeloma cell population after cytostatic treatment.

M. Boccadoro, A. Pileri, M. Bernengo, 1976, Haematologica.

Thymidine kinase, deoxycytidine kinase and deoxycytidylate deaminase activities in phytohaemagglutinin stimulated human lymphocytes.

M. Bernengo, L. Pegoraro, 1971, Experimental cell research.

Flow cytometry immunophenotyping in mycosis fungoides.

P. Quaglino, P. Savoia, M. Fierro, 2008, Journal of the American Academy of Dermatology.

A retrospective analysis of the costs and management of genital warts in Italy

M. Gianino, E. Lovato, M. Bernengo, 2013, BMC Infectious Diseases.

Immunomodulation and Sézary syndrome: experience with thymopentin (TP‐5)

M. Bernengo, A. Appino, M. Meregalli, 1988, The British journal of dermatology.

RT-PCR tyrosinase expression in the peripheral blood of melanoma patients

P. Quaglino, P. Savoia, S. Osella-Abate, 2004, Expert review of molecular diagnostics.

Granulomatous-ulcerative vulvar cryptococcosis in a patient with advanced HIV disease.

M. Bernengo, C. Tomasini, V. Caliendo, 1997, Journal of the American Academy of Dermatology.

Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.

C. Meijer, L. Cerroni, G. Hédelin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.

M. Felcht, C. Klemke, L. van der Fits, 2016, The Journal of investigative dermatology.

Gauze‐based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum

S. Bruschi, M. Fierro, P. Fava, 2014, International wound journal.

High‐dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha‐Habermann disease

P. Quaglino, M. Fierro, P. Fava, 2010, Dermatologic therapy.

Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections?

P. Quaglino, N. Mandras, V. Allizond, 2012, Dermatology.

Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts

P. Broganelli, M. Bernengo, A. Chiaretta, 2012, Dermatologic therapy.

Multiple pyogenic granuloma of the penis.

M. Bernengo, C. Tomasini, P. Puiatti, 1998, Sexually transmitted infections.

Variants of Parvovirus B19: Bioinformatical Evaluation of Nested PCR Assays

C. Castagnoli, M. Bernengo, R. Ponti, 2008, Intervirology.

Electrochemotherapy in the Treatment of Kaposi Sarcoma Cutaneous Lesions: A Two-Center Prospective Phase II Trial

S. Calvieri, T. Nardò, P. Quaglino, 2011, Annals of Surgical Oncology.

Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.

P. Quaglino, P. Savoia, S. Osella-Abate, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.

A. Sapino, S. Asioli, P. Quaglino, 2011, Surgical oncology.

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma.

P. Queirolo, M. Del Vecchio, N. Cascinelli, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status

D. Pacchioni, T. Nardò, P. Quaglino, 2007, Journal of Clinical Pathology.

Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course.

M. Bernengo, F. Lisa, M. Meregalli, 1983, Clinical immunology and immunopathology.

Keratinocytes express dipeptidyl‐peptidase IV (CD26) in benign and malignant skin diseases

P. Quaglino, M. Fierro, M. Bernengo, 1996, The British journal of dermatology.

Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP.

P. Quaglino, P. Savoia, M. Fierro, 1998, Leukemia & lymphoma.

Cutaneous melanoma metastases arising on a split-skin graft donor site.

P. Quaglino, P. Savoia, P. Fava, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases.

P. Quaglino, P. Savoia, M. Fierro, 2003, Journal of the American Academy of Dermatology.

Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program

P. Ascierto, A. Testori, E. Simeone, 2014, Cancer investigation.

Time course, clinical pathways, and long‐term hazards risk trends of disease progression in patients with classic mycosis fungoides

P. Zinzani, M. Fimiani, N. Pimpinelli, 2012, Cancer.

TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome.

L. Bonello, P. Quaglino, P. F. di Celle, 2010, The Journal of investigative dermatology.

Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients

T. Nardò, P. Quaglino, P. Savoia, 2007, Melanoma research.

Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.

S. Pileri, A. Pileri, S. Chimenti, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.

A. de Matteis, P. Quaglino, M. Fierro, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunohistologic findings and adhesion molecule pattern in primary pure cutaneous Rosai-Dorfman disease with xanthomatous features.

P. Quaglino, M. Bernengo, M. Novelli, 1998, The American Journal of dermatopathology.

What is the role of sensitization in uremic pruritus? An allergologic study.

G. Piccoli, M. Bernengo, G. Martina, 1991, Nephron.

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

P. Ascierto, A. Testori, E. Simeone, 2014, Journal of Translational Medicine.

After Surgery: Follow-Up Guidelines of Melanoma Patients

P. Quaglino, P. Savoia, P. Fava, 2013 .

Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.

P. Queirolo, B. Giannotti, A. Di Leo, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy

T. Nardò, P. Quaglino, P. Savoia, 2011, Pigment cell & melanoma research.

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

P. Ascierto, A. Testori, P. Queirolo, 2014, Journal of experimental & clinical cancer research : CR.

Diagnostic and Therapeutic Approaches in Italian Hospitals: Adjuvant and Metastatic Therapy in Melanoma

P. Ascierto, I. Stanganelli, A. Testori, 2013, Dermatology.

Skin metastases of malignant melanoma: a clinical and prognostic survey

Paola Savoia, Pietro Quaglino, T. Nardò, 2009, Melanoma research.

Cutaneous Metastases from Malignant Melanoma: Clinical Features and New Therapeutic Perspectives

P. Savoia, P. Fava, M. Bernengo, 2011 .

Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma).

P. Queirolo, M. Del Vecchio, N. Cascinelli, 1999, Melanoma research.

Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes

A. Sapino, R. Senetta, P. Quaglino, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Italian cohort of ipilimumab expanded access programme (EAP): Efficacy, safety, and correlation with mutation status in metastatic melanoma patients.

P. Ascierto, E. Simeone, P. Queirolo, 2013 .

Correlation between efficacy and toxicity in pts with pretreated advanced melanoma treated within the Italian cohort of the ipilimumab expanded access programme (EAP).

P. Ascierto, A. Testori, P. Queirolo, 2013 .

Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study

P. Quaglino, A. Ronco, M. Fierro, 2004, Melanoma research.

Melanoma in patients younger than 20 years.

P. Quaglino, S. Ribero, S. Osella-Abate, 2013, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?

P. Quaglino, P. Savoia, F. Cavallo, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.

P. Ascierto, S. Aamdal, L. Bastholt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).

M. Polansky, S. Lessin, E. Vonderheid, 2001, The Journal of investigative dermatology.

Metastatic melanoma of the heart

P. Savoia, A. Zaccagna, M. Fierro, 2000, Journal of surgical oncology.

T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.

M. Bernengo, F. Lisa, M. Meregalli, 1983, Thymus.

A treatment for metastatic melanoma?

P. Savoia, M. Bernengo, 1991 .

The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients

E. Berardesca, S. Chimenti, K. Peris, 2017, Advances in Therapy.

Dyskeratosis congenita with epidermodysplasia verruciformis of Lewandowsky and Lutz.

M. Bernengo, A. Zina, S. Bundino, 1978, Dermatologica.

Prognostic factors in Sézary syndrome.

P. Quaglino, P. Savoia, M. Fierro, 1994 .

Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study.

P. Savoia, G. Segoloni, S. Osella-Abate, 2011, European journal of dermatology : EJD.

[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)].

C. Stuardi, M. Bernengo, F. Lisa, 1986, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.

F. Orso, D. Taverna, E. Berardengo, 2012, Journal of dermatological science.

Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma.

A. Ardizzoni, M. Sertoli, A. Falcone, 1989, Oncology.

Phase II Study of Interferon α‐2a and Dacarbazine in Advanced Melanoma

N. Cascinelli, B. Giannotti, G. Zumiani, 1990 .

Erythrodermic CTCL: updated clues to diagnosis and treatment.

P. Quaglino, M. Bernengo, 2012, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Mycosis fungoides: disease evolution of the "lion queen" revisited.

A. Pileri, M. Fimiani, N. Pimpinelli, 2012, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Adult-onset cutaneous mastocytosis in monozygotic twins.

P. Quaglino, P. Savoia, M. Bernengo, 2011, Journal of the American Academy of Dermatology.

The European Ipilimumab Expanded Access Programme (EAP): Efficacy and Safety Data from the Italian Cohort of Patients with Pretreated, Advanced Melanoma

P. Ascierto, A. Testori, P. Queirolo, 2012 .

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

837 Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous (SC) interleukin-2 (IL-2) and interferon-alpha-2b (IFN) in metastatic melanoma

P. Queirolo, M. Sertoli, L. Gattinoni, 2003 .

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma

P. Queirolo, S. Gargiulo, P. Savoia, 2008, Pigment cell & melanoma research.

T‐cell receptor γ gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T‐cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings

L. Bonello, P. Quaglino, M. Bernengo, 2005, The British journal of dermatology.

Sézary syndrome

M. Bernengo, 2004 .

The relevance of the CD4+ CD26– subset in the identification of circulating Sézary cells

A. de Matteis, P. Quaglino, P. Savoia, 2001, The British journal of dermatology.

CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients.

P. Quaglino, P. Savoia, M. Fierro, 2003, Advances in Experimental Medicine and Biology.

Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.

P. Quaglino, P. Savoia, S. Osella-Abate, 2001, Journal of the American Academy of Dermatology.

Mantle zone lymphoma: an immunohistologic study of skin lesions.

M. Bernengo, M. Fierro, M. Bernengo, 1994, Journal of the American Academy of Dermatology.

Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients

P. Carli, S. Seidenari, G. Pellacani, 2007 .

THERAPEUTIC HOTLINE: A rare vandetanib‐induced photo‐allergic drug eruption

P. Quaglino, M. Fierro, P. Fava, 2010, Dermatologic therapy.

Multiple primary melanomas: analysis of 49 cases

P. Quaglino, P. Savoia, M. Bernengo, 1998, Melanoma research.

Prognostic F actors i n P rimary C utaneous L arge B -Cell Lymphomas: A E uropean M ulticenter S tudy

L. Cerroni, R. Willemze, J. Bosq, 2001 .

Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.

M. Fierro, M. Bernengo, M. Novelli, 1993, Melanoma research.

Mycosis fungoides in Patients under 20 Years of Age: Report of 7 Cases, Review of the Literature and Study of the Clinical Course

P. Quaglino, A. Zaccagna, M. Bernengo, 1999, Dermatology.

Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response

P. Quaglino, M. Bernengo, M. Bernengo, 2011, Dermatology.

Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T‐cell lymphomas and healthy subjects: lack of a pathogenic role

D. Alotto, P. Quaglino, M. Bernengo, 2008, The British journal of dermatology.

Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models.

R. Cavalli, P. Ferruti, E. Ranucci, 2015, Journal of biomedical nanotechnology.

Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma

P. Fava, M. Bernengo, A. Comessatti, 2008, Dermatology.

Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts

P. Broganelli, M. Bernengo, A. Chiaretta, 2012, Dermatologic therapy.

Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions.

B. Giannotti, L. Brogelli, S. Moretti, 1990, The Journal of investigative dermatology.

Deoxycytidylate deaminase activity and its template stability in human acute lymphoblastic and myeloblastic leukaemic cells.

M. Bernengo, L. Pegoraro, 1976, European journal of cancer.

Phase II study of oral panobinostat (LBH589), a potent pan-deacetylase inhibitor, in patients with refractory Cutaneous T-cell Lymphoma (CTCL)

P. Zinzani, F. Vanaclocha, M. Duvic, 2008 .

Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus

P. Savoia, T. Deboli, M. Bernengo, 2010, The Journal of dermatological treatment.

Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid

P. Quaglino, P. Savoia, M. Bernengo, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Zingoni A, Deboli T, Savoia P, Bernengo MG. Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus

P. Savoia, T. Deboli, M. Bernengo, 2022 .

Favourable prognostic role of regression of primary melanoma in AJCC stage I–II patients

R. Senetta, P. Quaglino, P. Savoia, 2013, The British journal of dermatology.

Disease progression in melanoma patients with negative sentinel lymph node: does false‐negative specimens entirely account for this phenomenon?

P. Quaglino, P. Savoia, S. Ribero, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Correlation with

M. Bernengo, B. Ubezio, Carlo, 2022 .

Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.

P. Ascierto, S. Aamdal, L. Bastholt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.